News | April 15, 2014

Mevion Announces Partnership With Chiyoda Technol for Distribution of Proton Therapy Systems in Japan

April 15, 2014 — Mevion Medical Systems announced an agreement with Chiyoda Technol Corp. for the exclusive distribution of the Mevion S250 proton therapy system in the Japanese market. Chiyoda Technol is one of Japan’s leading providers of radiation supply, service and monitoring.

The Mevion S250 system is a single-room, gantry-mounted proton accelerator that frees hospitals and private treatment facilities from the high costs, prohibitive space requirements and cumbersome workflow that commonly define the treatment modality.

“The significantly reduced size and cost of the Mevion S250, paired with cutting-edge technology, is a perfect fit for the very progressive Japanese radiation therapy market,” said Kazuhiko Yamaguchi, president of Chiyoda Technol Corp. “We have a strong tradition of introducing state-of-the-art medical products and with the addition of the Mevion S250 proton therapy system, we are fulfilling the demand of our foremost customers and we expect to significantly increase the number of proton therapy centers in the next five years.”

“Mevion is proud to expand its partnership with Chiyoda Technol to provide this revolutionary proton therapy platform to clinicians and patients in Japan”, said Joseph K. Jachinowski, CEO of Mevion. “With Japan’s 20-year leadership in the clinical use of proton therapy, the Japanese market has always been a high priority and we are excited to see the very positive response the Mevion S250 is receiving from all proton experts.”

The Mevion S250 is installed at the Kling Proton Therapy Center at Barnes-Jewish Hospital at Washington University in St. Louis, benefiting pediatric patients and other cancer patients where proton therapy treatment is indicated. Five additional systems are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City; First Coast Oncology in Jacksonville, Fla.; University of Florida Health Cancer Center at Orlando Health; and University Hospitals Seidman Cancer Center in Cleveland.

For more information:

Related Content

Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init